Moreover, the inhibition of GSK-3β in an AD model robustly decreased the oligomeric Aβ load in the mouse brain (DaRocha-Souto et al., 2012) and its activation augments PS1 to enhance the formation of Aβ42 (Zhang et al., 2020). Here, PSEN1 is linked to Alzheimer disease.